Investor Relations

Sensus Healthcare, Inc. (NASDAQ: SRTS) is a medical device company that is committed to enabling non-invasive and cost-effective treatment of non-melanoma skin cancers and keloids. Sensus uses a proprietary low energy x-ray radiation technology known as superficial radiation therapy (SRT), which is a result of over a decade of dedicated research and development activities. Sensus has successfully incorporated the SRT therapy into its portfolio of treatment devices, the SRT-100™ and SRT-100 Vision™. To date, the SRT technology has been used to effectively and safely treat oncological and non-oncological skin conditions in thousands of patients.

Contact Us

LHA Investor Relations
Kim Sutton Golodetz
212 838 3777
kgolodetz@lhai.com

Wednesday, May 3, 2023 04:30 PM Eastern

First Quarter 2023 Earnings

Thursday, February 9, 2023 04:30 PM Eastern

Fourth Quarter 2022 Earnings

Thursday, November 3, 2022 04:30 PM Eastern

3rd Quarter 2022 Earnings

Tuesday, September 27, 2022

34TH ANNUAL ROTH CONFERENCE

Wednesday, September 14, 2022 04:30 PM

H.C. Wainwright 24th Annual Global Investment Conference